Alterola Biotech (ABTI)
OTHER OTC:ABTI
US Market
Holding ABTI?
Track your performance easily

Alterola Biotech (ABTI) Financial Statements

11 Followers

Alterola Biotech Financial Overview

Alterola Biotech's market cap is currently ―. The company's EPS TTM is $-0.001; its P/E ratio is -5.88; Alterola Biotech is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -419.30K$ -2.63M$ -1.11M$ -123.16K$ -447.04K
EBITDA$ -419.30K$ -2.63M$ -1.11M$ -123.16K$ -447.04K
Net Income Common Stockholders$ -419.30K$ 477.93K$ -2.01M$ -123.16K$ -447.04K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 10.96K$ 2.65K$ 2.57K$ 9.10K$ 36.55K
Total Assets$ 11.97K$ 3.66K$ 3.59K$ 497.21K$ 12.69M
Total Debt$ 151.75K$ 145.60K$ 244.06K$ 1.55M$ 1.37M
Net Debt$ 140.79K$ 142.95K$ 241.49K$ 1.54M$ 1.34M
Total Liabilities$ 1.51M$ 1.33M$ 1.36M$ 2.52M$ 2.33M
Stockholders Equity$ -1.50M$ -1.33M$ -1.35M$ -2.02M$ 10.36M
Cash Flow-
Free Cash Flow$ 55.56K$ -73.59K$ -1.18M$ -103.26K$ 143.97K
Operating Cash Flow$ 55.56K$ -73.59K$ -1.18M$ -122.16K$ 310.82K
Investing Cash Flow--$ -35.00K$ 53.90K$ -166.85K
Financing Cash Flow$ 6.14K$ 179.29K$ 1.21M$ 7.08K$ -38.53K
Currency in USD

Alterola Biotech Earnings and Revenue History

Alterola Biotech Debt to Assets

Alterola Biotech Cash Flow

Alterola Biotech Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis